Phoenix Biotech Acquisition's Cash & cash equivalent grew by % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Phoenix Biotech Acquisition's Quick Ratio to 0.03, Quick Ratio remained below Phoenix Biotech Acquisition Corp average.

Within Biotechnology & Pharmaceuticals industry 141 other companies have achieved higher Quick Ratio than Phoenix Biotech Acquisition in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 0 to 4162.

Explain Quick Ratio?
How much Cash & cash equivalents PBAXU�s has?
What are PBAXU�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PBAXU Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	325.38 %	44.13 %	7.22 %	-10.28 %	-13.23 %
Y / Y Cash & cash equivalent Change	-86.41 %	-	-	-	-
Quick Ratio MRQ	0.03	-	0.2	-	0.86
PBAXU's Total Ranking	# 4162	# 0	# 0	# 2090	#
Seq. Current Liabilities Change	186.09 %	33.05 %	0.7 %	10.98 %	-3.07 %
Seq. Cash & cash equivalent Change	-	-	-	-	25.5 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 142
Healthcare Sector	# 886
Overall Market	# 4162

Quick Ratio Statistics
High	Average	Low
61.8	6.03	0.02
(Dec 31 2021)

Financial Statements
Phoenix Biotech Acquisition's Current Liabilities	$ 32 Millions	Visit PBAXU's Balance sheet
Phoenix Biotech Acquisition's Cash & cash equivalent	$ 1 Millions	Visit PBAXU's Balance sheet
Source of PBAXU's Sales		Visit PBAXU's Sales by Geography

Cumulative Phoenix Biotech Acquisition's Quick Ratio

PBAXU's Quick Ratio for the trailling 12 Months

PBAXU Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	84.84 %	5.62 %	-14.15 %	-3.79 %	15.21 %
Y / Y Cash & cash equivalent TTM Growth	-77.95 %	58.17 %	-	-53.24 %	-53.47 %
Quick Ratio TTM	0.04	0.23	0.41	0.37	0.36
Total Ranking TTM	# 4175	# 2928	# 3066	# 3087	#
Seq. Current Liabilities TTM Growth	69.02 %	10.69 %	1.8 %	-2.95 %	-3.42 %
Seq. Cash & cash equivalent TTM Growth	-68.56 %	-38.73 %	14.49 %	0 %	125.5 %

Quick ratio ranking by company, industry and sector >> Back to PBAXU Financial Strength Comparisons >> Go to Compare PBAXU Quick Ratio to its Competitors

On the trailing twelve months basis Due to unchanged in Current Liabilities in the Q2 2026 to $32.41 millions, cumulative Quick Ratio decreased to 0.04 below the Phoenix Biotech Acquisition Corp average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 146 other companies have achieved higher Quick Ratio than Phoenix Biotech Acquisition. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2928 to 4175.

Explain Quick Ratio?
How much Cash & cash equivalents PBAXU�s has?
What are PBAXU�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Biotechnology & Pharmaceuticals Industry	# 147
Healthcare Sector	# 921
Within the Market	# 4175

trailing twelve months Quick Ratio Statistics
High	Average	Low
3.12	0.64	0.02
(Jun 30 2022)		(Sep 30 2023)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Biotechnology & Pharmaceuticals Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Bioatla Inc	0.06	$ 1.544 Millions	$ 23.951 Millions
Viskase Holdings inc	0.06	$ 7.911 Millions	$ 123.630 Millions
Biomx Inc	0.06	$ 0.585 Millions	$ 10.180 Millions
Tevogen Bio Holdings Inc	0.06	$ 1.082 Millions	$ 19.573 Millions
Phoenix Biotech Acquisition Corp	0.03	$ 0.888 Millions	$ 32.405 Millions
Tradeup Acquisition Corp	0.01	$ 0.100 Millions	$ 9.256 Millions

Date modified: 2026-09-26T07:40:43+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.